Paula R Pohlmann
22PUBLICATIONS
163CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (22)
Sort by Publication Date:
|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf
|Nov 24, 2025
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach.Taiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav
|Aug 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.Camila Braganca Xavier, Clark R Andersen, JoAnn Lim
|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.Denise M Wolf, Christina Yau, Michael Campbell
|Feb 07, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.Kim A Reiss, Mathew G Angelos, E Claire Dees
|Jan 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe
Pageof 4
Frequent Collaborators
7 joint publications
Gillian L Hirst
6 joint publications
Laura van 't Veer
6 joint publications
Claudine Isaacs
6 joint publications
Lamorna Brown-Swigart
6 joint publications
Laura J Esserman
6 joint publications
Angela M DeMichele
5 joint publications
Rita Nanda
5 joint publications
Hope S Rugo
5 joint publications
Douglas Yee
4 joint publications
W Fraser Symmans
